Skip to content
10-K

Annual Report

Onconetix, Inc. ONCO

0001213900-26-027725

← back to feed
Filed
Mar 13, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 11, 2026 3.58M sh
Shares Diluted FY 2025 · Dec 31, 2025 937.69K sh
Shares Diluted restated FY 2025 · Dec 31, 2024 32.3K sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$9.68M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$10.5M
Current Liabilities FY 2025 · Dec 31, 2025 $9.14M
Current Liabilities FY 2025 · Dec 31, 2024 $18.29M
Total Liabilities FY 2025 · Dec 31, 2025 $9.16M
Total Liabilities FY 2025 · Dec 31, 2024 $18.57M
Current Assets FY 2025 · Dec 31, 2025 $6.07M
Current Assets FY 2025 · Dec 31, 2024 $950.27K
Total Assets FY 2025 · Dec 31, 2025 $24.93M
Total Assets FY 2025 · Dec 31, 2024 $28.18M
Eps Diluted FY 2025 · Dec 31, 2025 −$16.56
Eps Diluted restated FY 2025 · Dec 31, 2024 −$1,823.39
Eps Basic FY 2025 · Dec 31, 2025 −$16.56
Eps Basic restated FY 2025 · Dec 31, 2024 −$1,823.39
Sga Expense FY 2025 · Dec 31, 2025 $7.04M
Sga Expense FY 2025 · Dec 31, 2024 $11.23M
Net Income FY 2025 · Dec 31, 2025 −$14.03M
Net Income FY 2025 · Dec 31, 2024 −$58.69M
Operating Income FY 2025 · Dec 31, 2025 −$17.86M
Operating Income FY 2025 · Dec 31, 2024 −$56.49M
Gross Profit FY 2025 · Dec 31, 2025 $632.91K
Gross Profit FY 2025 · Dec 31, 2024 $1.06M
Cost Of Revenue FY 2025 · Dec 31, 2025 $182.46K
Cost Of Revenue FY 2025 · Dec 31, 2024 $1.47M
Capex FY 2025 · Dec 31, 2024 $28.47K